Glaxosmithkline Australia Pty Ltd

Status: Registered
Address mentioned in a 2012 contract: 1061 Mountain Highway , Melbourne
Current name since: 2002-07-01
Name in the ASICs register: Glaxosmithkline Australia Pty Ltd
Australian Company Number: 100162481
Australian Business Number: 47100162481
Registration date: 2002-04-09
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Glaxosmithkline Australia Pty Ltd is a limited by shares Australian proprietary company. Located at VIC 3067 since 2023-08-13 the company is, as the updated on 2023-08-13 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2002-07-01. Known company numbers for Glaxosmithkline Australia Pty Ltd are as follows: ACN - 100162481, Australian Business Number - 47100162481. Glaxosmithkline Australia Pty Ltd has been the company name since 2002-07-01. Glaxosmithkline Australia Pty Ltd is one of the trading names this company has used, to be specific, the trading names list includes 15 positions that is Glaxosmithkline Australia Pty Ltd since 2003-10-09, Glaxosmithkline Australia Pty Ltd since 2003-09-25 to 2003-10-09, and Allen & Hanburys since 2003-09-25. Gsk Melbourne is an example of a business name Glaxosmithkline Australia Pty Ltd used. The complete list includes 40 business names. Gsk Melbourne was the company's business name from 2023-07-11. Other business names include Stiefel, A Gsk Company and Stiefel, A Gsk Company (from 2010-07-05 to 2019-11-14). Their official company name changed on 2002-04-24 to Gsk Operations Pty Ltd. The company had used this name up until 2002-08-10. This Australian proprietary company was previously located in VIC 3155 (from 2014-09-21 to 2023-08-13), VIC 3155 (from 2014-01-11 to 2014-09-21), VIC 3155 (from 2002-04-24 to 2014-01-11).

Details for ABN 47100162481

Type: Australian Private Company

ABN Status

Status From To
Active 2002-04-24 current

Main Name

Name From To
Glaxosmithkline Australia Pty Ltd 2002-08-10 current
Gsk Operations Pty Ltd 2002-04-24 2002-08-10

Business Names

Name From To
Gsk Melbourne 2023-07-11 current
Stiefel, A Gsk Company 2010-07-12 current
Stiefel, A Gsk Company 2010-07-05 2019-11-14
Stiefel, A Gsk Company 2010-07-01 2021-01-27
Real Rl 2005-07-27 2011-09-05
Real Rl 2005-07-19 2011-10-21
Real Rl 2005-07-18 2011-07-18
Real Rl 2005-06-06 2011-11-28
Beecham 2003-05-07 2018-06-25
Smithkline 2003-02-13 2020-12-16
Smithkline 2003-02-12 2022-08-04
Smithkline 2003-02-05 2009-03-16
Beecham 2003-02-01 2012-05-07
Smithkline 2003-01-15 2012-04-26
Diversified Health Systems 2002-08-20 2007-07-31
Smithkline Beecham International 2002-07-05 2003-03-05
Beecham Research Laboratories 2002-07-02 2003-03-04
Glaxo 2002-07-01 2011-07-11
Menley & James 2002-07-01 2009-10-19
Smithkline Beecham International 2002-07-01 2003-01-01
Diversified Health Systems 2002-07-01 2002-08-19
Glaxosmithkline Consumer Healthcare 2002-07-01 2010-10-07
Beecham Research Laboratories 2002-07-01 2003-01-01
Smith Kline & French Laboratories 2002-07-01 2003-01-01
Allen And Hanburys 2002-07-01 2012-04-26
Allen & Hanburys 2002-07-01 2011-07-31
Beecham Research Laboratories 2002-04-24 2003-01-01
Smith Kline & French Laboratories 2002-04-24 2003-01-01
Menley & James 2002-04-24 2009-10-19
Glaxo 2002-04-24 2011-07-11
Smithkline Beecham International 2002-04-24 2003-03-05
Allen & Hanburys 2002-04-24 2015-12-11
Panadol 2002-04-24 current
Vita Valu Laboratories 2002-04-24 2020-12-03
Diversified Health Systems 2002-04-24 2003-01-07
Glaxosmithkline 2002-04-24 2015-12-12
Bonnington & Co 2002-04-24 2020-12-03
Childrens Panadol 2002-04-24 current
Allen And Hanburys 2002-04-24 2012-04-26
Glaxosmithkline Consumer Healthcare 2002-04-24 2015-06-25

Trading Names

Name From To
Glaxosmithkline Australia Pty Ltd 2003-10-09 current
Glaxosmithkline Australia Pty Ltd 2003-09-25 2003-10-09
Allen & Hanburys 2003-09-25 current
Bonnington & Co 2003-09-25 current
Childrens Panadol 2003-09-25 current
Glaxo 2003-09-25 current
Beecham 2003-09-25 current
Diversified Health Systems 2003-09-25 current
Glaxosmithkline 2003-09-25 current
Glaxosmithkline Consumer Healthcare 2003-09-25 current
Menley & James 2003-09-25 current
Panadol 2003-09-25 current
Smithkline 2003-09-25 current
Vita-valu Laboratories 2003-09-25 current
Wellcome 2003-09-25 current

Main Location

Location From To
VIC 3067 2023-08-13 current
VIC 3155 2014-09-21 2023-08-13
VIC 3155 2014-01-11 2014-09-21
VIC 3155 2002-04-24 2014-01-11

Goods & Services Tax (GST)

Status From To
Registered 2002-07-01 current

Advertisements

Company Patents

Patent Application Number: 2013234139

General information:

Application date: 2014-08-22
Patent status: Filed

The specification prior to acceptance and where the application has not lapsed

Patent type: NPE
Primary IPC mark: C12N 15/82
WIPO Application Number: WO2013/136057
Original WIPO Application Number: WO13/136057
PCT Application Number: PCT/GB2013/050599
Original PCT Application Number: PCT/GB13/50599

International Patent Classification:

IPC Mark: A01H 5/00
Version date of the IPC Classification record: 2006-01-01
Section code: A - human necessities
Class code: 1 - agriculture; forestry; animal husbandry; hunting; trapping; fishing
Subclass code: H - new plants or processes for obtaining them; plant reproduction by tissue culture techniques
Main group code: 5 - flowering plants, i.e. angiosperms
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: 2013-11-14
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Expiry date: 2033-03-12
Earliest priority date: 2012-03-13
WIPO publication date: 2013-09-19
Effective patent date: 2013-03-12
Patent in force to: 2017-03-12

Patent Application Number: 2011268698

General information:

Application date: 2012-12-12
Patent status: Accepted

Found to have no further lawful grounds of objection by the examiner. For innovation patents, acceptance is automatic following payment of fees.

Patent type: NPE
Primary IPC mark: C07K 14/415
WIPO Application Number: WO2011/161431
Original WIPO Application Number: WO11/161431
PCT Application Number: PCT/GB2011/051121
Original PCT Application Number: PCT/GB11/51121
Accepted claims count: 26

International Patent Classification:

IPC Mark: C07K 14/415
Version date of the IPC Classification record: 2006-01-01
Section code: C - chemistrymetallurgy
Class code: 7 - organic chemistry
Subclass code: K - peptides (peptides containing -lactam rings c07d; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d; ergot alkaloids of the cyclic peptide type c07d0519020000; genetic engineering processes for obtaining peptides c12n0015000000)
Main group code: 14 - peptides having more than 20 amino acids; gastrins; somatostatins; melanotropins; derivatives thereof
Subgroup code: 415 - from plants
Mark type: First (ie Primary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: 2012-09-27
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Examination request filing date: 2013-03-13
Requested examination type: Request Full Examination
First report issue date: 2014-03-26
Examination section: C2 Chemistry
Expiry date: 2031-06-16
Earliest priority date: 2010-06-22
Acceptance Notice date: 2015-03-05
WIPO publication date: 2011-12-29
Effective patent date: 2011-06-16
Patent in force to: 2015-06-16

Government contract data

Latest 2016 contracts

Date Description Agency Value
2016-08-03 Drugs and Pharmaceutical Products Department of Health
12 156 018.34
2016-08-03 Drugs and Pharmaceutical Products Department of Health 9 758 000.00
2016-08-03 Drugs and Pharmaceutical Products Department of Health 2 170 000.00

Latest 2015 contracts

Date Description Agency Value
2015-03-13 Drugs and Pharmaceutical Products Department of Health
864 266.32

Latest 2014 contracts

Date Description Agency Value
2014-07-10 Drugs and Pharmaceutical Products Department of Health
1 360 798.83
2014-07-10 Drugs and Pharmaceutical Products Department of Health 18 918 480.97
2014-07-10 Drugs and Pharmaceutical Products Department of Health 2 321 860.23

Latest 2013 contracts

Date Description Agency Value
2013-08-13 Drugs and Pharmaceutical Products Department of Health
17 459 200.00
2013-08-13 Drugs and Pharmaceutical Products Department of Health 53 495 351.44
2013-07-01 Drugs and Pharmaceutical Products Department of Health 1 742 218.87

Latest 2012 contracts

Date Description Agency Value
2012-02-10 Comprehensive health services Department of Health
14 735 308.71
2012-02-10 Comprehensive health services Department of Health 46 544 399.86

Latest 2011 contracts

Date Description Agency Value
2011-04-01 Drugs and Pharmaceutical Products Department of Health
19 750 500.00

Latest 2009 contracts

Date Description Agency Value
2009-08-18 Drugs and Pharmaceutical Products Department of Health
4 320 000.00
2009-07-01 Drugs and Pharmaceutical Products Department of Health 43 200 000.00
2009-01-19 Drugs and Pharmaceutical Products Defence Materiel Organisation 31 995.04

Latest 2008 contracts

Date Description Agency Value
2008-11-03 Drugs and Pharmaceutical Products Defence Materiel Organisation
416 240.00
2008-11-03 Drugs and Pharmaceutical Products Defence Materiel Organisation 182 160.00
2008-11-03 Drugs and Pharmaceutical Products Defence Materiel Organisation 37 287.54

Latest 2007 contracts

Date Description Agency Value
2007-12-14 Drugs and Pharmaceutical Products Defence Materiel Organisation
10 631.50
2007-12-12 Drugs and Pharmaceutical Products Defence Materiel Organisation 341 275.00
2007-12-05 Drugs and Pharmaceutical Products Defence Materiel Organisation 10 631.50

Find company

Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.